Currently, there are 40 states in the U.S. that have adopted medical cannabis legalization measures, with many of those states permitting legal sales of medical cannabis products. A standard requirement for states that permit legal product sales is that the products undergo testing for various contaminants before being sold, although state-level standards vary from market to market.
According to a recent national survey, 91.7% of respondents want medical cannabis to be ‘decontaminated.’ The survey was commissioned by XRPure, a cutting-edge X-ray decontamination company that provides solutions for the cannabis industry, ensuring product safety and integrity with minimal impact on quality.
“While there is significant support for the decontamination of cannabis to eliminate harmful pathogens such as mold and bacteria, most individuals are still unaware of how this is achieved and the various technologies behind it.” stated XRPure in a press release obtained by Cannabis Industry Data.
“According to a survey today of over 500 Americans, commissioned by XRPure, an overwhelming 91.7% of respondents believe medical cannabis should be decontaminated. Similarly, 90.5% agree that cannabis brands should be required to label their packaging if the product has been decontaminated. Yet, when it comes to understanding the available methods—X-ray, ozone, and radiofrequency (RF) technologies—only 1 in 4 respondents (26.4%) said they were confident in their knowledge.” XRPure also stated.
“This survey reflects a major gap in awareness of how we can make cannabis cleaner and safer to consume,” said Jeff Adams, Founder and Managing Director of XRPure. “Consumers are clearly demanding transparency and safety in their cannabis products, but we as an industry need to do a better job in fully communicating how those safety standards are met.”
Additional findings from the recent survey include:
- 53.7% said they would be more likely to purchase decontaminated cannabis flower
- Only 15.7% would be less likely to do so
- 43.8% of respondents admitted they do not understand the differences between the main decontamination methods used today
“This all starts with labeling, but we need to strive to go beyond that,” added Adams. “If we’re going to foster trust in the cannabis industry and ensure product safety, we must also invest in educating consumers about what decontamination is, why it matters, and how it’s done.”
XRPure commissioned SurveyMonkey to conduct its survey of 500 anonymous Americans ages 18 and up. The survey was conducted in May 2025.